> Symposium Cell therapy for ARDS and sepsis
I have forgotten my password
08:30 - 10:30
Cell therapy for ARDS and sepsis
After this session the attendees will understand the basic mechanisms and the roles of cell therapy in preclinical models of lung injury and severe sepsis and how to lead and implement first-in-human trials of lung cell therapy.
Target audience :
Anaesthesiologist, Immunologist, Intensivist/critical care physician, Microbiologist, Pulmonologist, Researcher, Resident, Scientist, Thoracic surgeon
Milano (MI) (Italy)
Sabadell (Barcelona) (Spain)
Therapeutic efficacy of human mesenchymal cells (MSCs) in the repair of ARDS and VILI
J. Laffey(Galway, Ireland)
Type II pneumocyte transplantation in ARDS
R. Guillamat Prats(Badalona, Spain)
MSC therapy as adjuntive treatment in severe sepsis
M. Matthay(San Francisco, United States)
What are the barriers to clinical translation of MSC for ARDS?
D. Mcauley(Belfast (Belfast), United Kingdom)
. . .